Thanks patiencel and Sampson77, I think you are probably right an each count, but it is a pretty huge unknown for a company with a market cap of $10m. Where I think there really is some hope is in the nasal delivery of pharmaceuticals. This one could be a biggy.
Ann: Annual Report to shareholders , page-33
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
